Ingle

A combination of two potent anti-cancer drugs appears to halt the progression of the most serious cases of breast cancer in elderly women, according to a government study.Women over age 64 with advanced breast cancer who received the combination treatment lived about seven months longer than women receiving only one of the drugs, reported Dr. James N. Ingle of the Mayo Clinic in Rochester, Minn.The American Cancer Society projects 175,000 new cases of breast cancer in the United States this year and 44,800 deaths from the disease.